Grosso, A M <br/><br/>
Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis.  [electronic resource] 

 -  International journal of clinical practice  Mar 2011 
 - 253-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1742-1241 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-1241.2011.02633.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiotensin II Type 1 Receptor Blockers--economics<br/>Benzimidazoles--economics<br/>Biphenyl Compounds<br/>Clinical Trials as Topic<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Female<br/>Heart Failure--drug therapy<br/>Humans<br/>Hypertension--drug therapy<br/>Losartan--economics<br/>Male<br/>Middle Aged<br/>Quality-Adjusted Life Years<br/>Risk Factors<br/>Tetrazoles--economics<br/>Young Adult